|
Dehydroepiandrosterone Effects on HIV-1 Replication Clinical Trials Information presented on Clinical Trials Search isn't designed to be a substitute for certified healthcare advice, travels to or professional assistance using a genuine medical doctor. We are not physicians. Always confer with your dr. about Dehydroepiandrosterone Effects on HIV-1 Replication conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Dehydroepiandrosterone Effects on HIV-1 Replication Clinical research trials and Dehydroepiandrosterone Effects on HIV-1 Replication medical trials happen in hundreds of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectualness of new drugs. The intention of the studies / undertakings is to solve certain human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all forms of circumstances, such as Dehydroepiandrosterone Effects on HIV-1 Replication. Dehydroepiandrosterone Effects on HIV-1 Replication Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment choices before they are available to the general public. Some times the human subjects get treatment for free of charge, and sometimes they are paid for their time. Occasionally there is a cost for a Dehydroepiandrosterone Effects on HIV-1 Replication clinical trial. Participants frequently get the best healthcare available for their Dehydroepiandrosterone Effects on HIV-1 Replication condition. Risks are a reality, nonetheless, and can include extra or frequent physician trips, medical risks (possibly life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with exacting guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "D" Clinical Trials Conditions > Dehydroepiandrosterone Effects on HIV-1 Replication  Dehydroepiandrosterone Effects on HIV-1 Replication
Dehydroepiandrosterone Effects on HIV-1 Replication
For Condition: HIV Infections
Status: No longer recruiting
Sponsor(s): National Center for Complementary and Alternative Medicine (NCCAM) ,
Synopsis: This study's purpose is to learn how dehydroepiandrosterone (DHEA) affects the HIV virus, the immune system, hormone levels, body composition and quality of life.
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Crossover Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion criteria: - Evidence of HIV-1 infection - HIV RNA <50 copies/mL - Stable antiretroviral treatment regimen for at least 8 weeks - Age 18 years or older - Normal pap smear and mammograph within 1 year (females) - Normal prostate-specific antigen level with in one year, age adjusted (males) Exclusion criteria: - Active opportunistic infections or malignancy other than localized cutaneous KS lesions - Concurrent or prior use within the past 8 weeks of DHA, testosterone, other anabolic steroids, corticosteroids, megestrol acetate, growth hormone, IL-2, or thalidomide - Diagnosis of AIDS Dementia Complex (stage II or higher) - Active substance abuse (e.g., alcohol or injection drugs) - Evidence of severe liver dysfunction or hepatic transaminases greater than 3x the upper normal limit - Pregnant or breast-feeding - History of endocrinologically-responsive tumors (e.g., breast, ovarian, uterine, or prostatic cancer, or malignant melanoma)
Total Enrollment: 40
Location and Contact Information:
Community Consortium
San Francisco, California, 94110
United States
Additional Information:
Study ID Numbers: 1 R01 AT00512-01; Abrams
Study Start Date: October 2000
Record last reviewed: March 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00065104
Other Hiv Infections Studies:
1. Phase I Rising Dose Tolerability Study of SC-48334 in Patients With Acquired Immunodeficiency Syndrome (AIDS) and Advanced AIDS Related Complex
2. The Effects of Anti-HIV Drugs on the HIV Virus in HIV-Infected Patients
3. A Study to Evaluate the Effect of Anti-HIV Therapy on Lean Tissue (Muscle) in HIV-Positive Patients
4. 4-Day-A-Week Treatment Plan for HIV Infected Adolescents
5. A Phase I Study of Combination Therapy With Didanosine (ddI) and Ribavirin in HIV-Infected Children.
Related Studies:
Other HIV Infections Clinical Trials
Other California Clinical Trials
Other San Francisco Clinical Trials
Dehydroepiandrosterone Effects on HIV-1 Replication
|
|
|
|
|
|
|
|
